Pathstone Family Office, LLC Inovio Pharmaceuticals, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Inovio Pharmaceuticals, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 148,392 shares of INO stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,392
Previous 33,403
344.25%
Holding current value
$1.33 Million
Previous $15,000
280.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding INO
# of Institutions
14Shares Held
292KCall Options Held
0Put Options Held
0-
ETF Managers Group, LLC Summit, NJ86.4KShares$771,2480.0% of portfolio
-
Brainard Capital Management LLC Austin, TX16.7KShares$148,8270.01% of portfolio
-
Tiaa, Fsb St. Louis, MO14.4KShares$128,4400.0% of portfolio
-
Personal Capital Advisors Corp11.3KShares$100,9090.0% of portfolio
-
Prime Capital Investment Advisors, LLC Overland Park, KS10.2KShares$90,8350.0% of portfolio
About INOVIO PHARMACEUTICALS, INC.
- Ticker INO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 249,400,000
- Market Cap $2.23B
- Description
- Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...